<DOC>
	<DOCNO>NCT00941577</DOCNO>
	<brief_summary>To assess efficacy inhaled AIR645 suppression Asthmatic Responses subject mild asthma inhale allergen .</brief_summary>
	<brief_title>Study Evaluating Effects AIR645 Allergen-Induced Airway Responses Subjects With Mild Atopic Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Men woman well control mild allergic asthma , age 18 65 year Only asthma med shortacting bronchodilator use twice weekly FEV1 great 70 % predict demonstrated baseline late response allergen induction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Hypersensitivity</keyword>
	<keyword>Lung Diseases , Obstructive</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Bronchial Diseases</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Hypersensitivity , Immediate</keyword>
	<keyword>Asthma</keyword>
	<keyword>Respiratory Hypersensitivity</keyword>
</DOC>